Abstract

The aim of this study was to isolate and identify angiotensin I-converting enzyme (ACE) inhibitory peptides from sesame protein through simulated gastrointestinal digestion in vitro, and to explore the underlying mechanisms by molecular docking. The sesame protein was enzymatically hydrolyzed by pepsin, trypsin, and α-chymotrypsin. The degree of hydrolysis (DH) and peptide yield increased with the increase of digest time. Moreover, ACE inhibitory activity was enhanced after digestion. The sesame protein digestive solution (SPDS) was purified by ultrafiltration through different molecular weight cut-off (MWCO) membranes and SPDS-VII (< 3 kDa) had the strongest ACE inhibition. SPDS-VII was further purified by NGC Quest™ 10 Plus Chromatography System and finally 11 peptides were identified by Nano UHPLC-ESI-MS/MS (nano ultra-high performance liquid chromatography-electrospray ionization mass spectrometry/mass spectrometry) from peak 4. The peptide GHIITVAR from 11S globulin displayed the strongest ACE inhibitory activity (IC50 = 3.60 ± 0.10 μM). Furthermore, the docking analysis revealed that the ACE inhibition of GHIITVAR was mainly attributed to forming very strong hydrogen bonds with the active sites of ACE. These results identify sesame protein as a rich source of ACE inhibitory peptides and further indicate that GHIITVAR has the potential for development of new functional foods.

Highlights

  • Hypertension is one of the diseases with the highest mortality in the world, and it is the main pathogenesis factor of coronary heart disease, stroke, and heart and kidney failure [1,2,3]

  • To enhance the angiotensin I-converting enzyme (ACE) inhibition, sesame protein digestive solution (SPDS)-VII was further purified by NGC QuestTM 10 Plus Chromatography System

  • The degree of hydrolysis (DH), peptide yield, and ACE inhibition at different time points were determined during simulated gastrointestinal digestion, which demonstrated that the DH, peptide yield increased with the increase of digest time

Read more

Summary

Introduction

Hypertension is one of the diseases with the highest mortality in the world, and it is the main pathogenesis factor of coronary heart disease, stroke, and heart and kidney failure [1,2,3]. Relevant studies have shown that human blood pressure is regulated by many factors, among which renin-angiotensin system (RAS) and kallikrein kinin system (KKS) are the main ways to control the stability of blood pressure. In the RAS system, ACE can convert the inactive angiotensin I into angiotensin II, which has the function of constricting vascular smooth muscle, increases the blood pressure. ACE can inactivate the vasodilator bradykinin in the KKS system, leading to vasoconstriction, which causes an increase in the blood pressure [5].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call